7-Ethyl-10-hydroxycamptothecin
SIGMA/H0165 - ≥98% (HPLC), powder
Synonym: SN-38
CAS Number: 86639-52-3
Empirical Formula (Hill Notation): C22H20N2O5
Molecular Weight: 392.40
MDL Number: MFCD00871873
Linear Formula: C22H20N2O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| biological source | Artemisia annua |
| form | powder |
| InChI | 1S/C22H20N2O5/c1-3-12-13- |
| InChI key | FJHBVJOVLFPMQE-QFIPXVFZSA |
| Quality Level | 200 ![]() |
| SMILES string | OC1=CC2=C(CC)C(C3)=C(N=C2 |
| solubility | DMSO: 1 mg/mL |
| storage temp. | −20°C |
| Application: | 7-Ethyl-10-hydroxycamptot • to inhibit enterovirus 71 (EV71) (H) infection • to screen the chemosensitivity of pancreatic adenocarcinoma cells • as a chemical to study its ability to reverse multidrug resistance (MDR), due to ATP binding cassette (ABC) transporters |
| Biochem/physiol Actions: | Active metabolite of irinotecan. Inhibitor of topoisomerase I. |
| Biochem/physiol Actions: | Active metabolite of irinotecan. Inhibitor of topoisomerase I.. Gene expression analysis of colon cancer cell lines treated with SN-38 showed differential effects: the majority of affected genes were down-regulated (including, most strongly, genes related to receptor and kinase activity, signal transduction, apoptosis, RNA processing, protein metabolism and transport, cell cycle and transcription. Some of the up-regulated genes were involved in apoptosis, transcription, development and differentiation. |
| Packaging: | 10 mg in glass bottle |
| Packaging: | 50 mg in poly bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 - H360D - H372 |
| Precautionary statements | P201 - P202 - P260 - P264 - P301 + P312 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352204 |



